Oaktree Acquisition Corp. III Life Sciences (OACC)
NGM · Financial Services · Shell Companies
$10.66
+0.00%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$210.9M
Shares Outstanding
19.8M
Exchange
NGM
Currency
USD
About Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -270K | -226K | -255K | -457K |
| Net Income | 1.9M | 2.0M | 1.8M | 1.4M |
| Diluted EPS | $0.08 | $0.08 | $nan | $0.06 |
Annual Financials
| Metric | 2025-12-31 |
|---|---|
| Revenue | 0.00 |
| Operating Income | -1.2M |
| Net Income | 7.3M |
| Diluted EPS | $0.30 |